SCHEMBL10220904

SCHEMBL10220904

NC(=O)c1c(F)cnc(OCc2nc(-c3ccc(Cl)cc3)cs2)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.49
RAB9A P51151 6/20 0.49
NPC1 O15118 4/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 5/20 0.46
MAPT P10636 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
PPARD Q03181 1/20 0.46
LMNA P02545 2/20 0.43
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
LTA4H P09960 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAP4K4 O95819 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16181390 0.93 L3MBTL1 (0.50) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL10220907 0.86 L3MBTL1 (0.49) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL203769 0.85 PPARD (0.52) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL16181396 0.83 L3MBTL1 (0.43) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL16181395 0.82 MEN1 (0.45) L3MBTL1RAB9ANPC1ALDH1A1MAPT
SCHEMBL2704589 0.82 PPARD (0.52) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL16181397 0.80 L3MBTL1 (0.52) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL4567032 0.80 L3MBTL1 (0.41) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL10220910 0.80 L3MBTL1 (0.41) L3MBTL1RAB9ANPC1TDP1ALDH1A1
SCHEMBL10220905 0.80 L3MBTL1 (0.49) L3MBTL1RAB9ANPC1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20120122918-A1 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-05-17 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122918-A1 ANTIBACTERIAL AGENTS ALK, ROS1, ARG1 L3MBTL1 297/4885RAB9A 1213/4885NPC1 2815/4885
US-20130072520-A2 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 L3MBTL1 703/4885RAB9A 2799/4885NPC1 1400/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 L3MBTL1 703/4885RAB9A 2799/4885NPC1 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.